Former Theranos CEO Denied Attorney-Client Privilege Over Communications with Company Attorneys; District of Massachusetts Allows Putative Securities Class Action to Proceed Against OvaScience Investors; Delaware Chancery...more
6/16/2021
/ Attorney-Client Privilege ,
Board of Directors ,
Breach of Duty ,
Client Representation ,
Coronavirus/COVID-19 ,
Corporate Officers ,
Derivative Suit ,
Dismissals ,
Engagement Letters ,
Fiduciary Duty ,
Health and Safety ,
Initial Public Offering (IPO) ,
Insider Trading ,
Investors ,
Public Statements ,
Putative Class Actions ,
Securities Litigation ,
Securities Violations ,
Shareholders ,
Standing ,
Unjust Enrichment